DarioHealth Corp. (DRIO)
NASDAQ: DRIO · IEX Real-Time Price · USD
1.140
-0.090 (-7.32%)
Apr 15, 2024, 4:30 PM EDT - Market closed

Company Description

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand.

Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems.

It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services.

The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.

DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

DarioHealth Corp.
DarioHealth logo
Country United States
Founded 2011
Industry Diagnostics & Research
Sector Healthcare
Employees 276
CEO Erez Raphael

Contact Details

Address:
322 W 57th St. #33b
New York, New York 10019
United States
Phone 972-4-770-6377
Website mydario.com

Stock Details

Ticker Symbol DRIO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001533998
CUSIP Number 23725P209
ISIN Number US23725P2092
Employer ID 45-2973162
SIC Code 3841

Key Executives

Name Position
Erez Raphael Chief Executive Officer and Director
Richard A. Anderson President
Zvi Ben David CPA Chief Financial Officer, Treasurer and Secretary
Dov Oppenheim Co-Founder and Production Chief
Tomer Ben-Kiki Chief Operating Officer
Josh Fischer Senior Vice President of Operations and Compliance
Claudia Levi Content and Communications Manager
Mary Mooney Vice President of Marketing
Limor Drezner Chief People Officer
Jean Christophe Muyl Head of Commercialization North America

Latest SEC Filings

Date Type Title
Apr 5, 2024 8-K Current Report
Mar 28, 2024 10-K Annual Report
Mar 1, 2024 8-K Current Report
Feb 29, 2024 D Notice of Exempt Offering of Securities
Feb 22, 2024 8-K Current Report
Feb 21, 2024 S-8 Securities to be offered to employees in employee benefit plans
Feb 21, 2024 8-K Current Report
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 6, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 19, 2024 S-8 Securities to be offered to employees in employee benefit plans